Member of the board since 2015
Karin Meyer is the president of the Swedish Pharmaceutical Society. Previously, she was the CEO of PCG Clinical Services AB and PCG Solutions AB and business manager at Uppsala University. She has worked on clinical trials at Quintiles and has also been CEO of Quintiles Scandinavia. Furthermore, Karin has worked with health economics in clinical trials at AstraZeneca and as a manager at the Medical Products Agency. Karin is a board member of several Life Science companies.
Karin is independent in relation to the Company and its senior executives as well as independent in relation to major shareholders.
number of shares
500 shares as well as 12 500 warrants.